Synapse
⌘+K
Sign In
Sign Up for Free
Synapse
Sign In
Sign Up for Free
Home
Communities
Explore
More
Language
English
English
Medical Plus
h-index: 27
Total citations: 3,440
Total papers: 156
Homepage:
https://www.medicalplus.cz/
Recent papers from Medical Plus
Association of ultrasound parameters of visceral and subcutaneous adipose tissue with carotid artery atherosclerosis in the kyrgyz ethnic group
Russian Cardiology Bulletin · 2026
Understanding the Educational Needs of Primary Care Providers Around Post-Intensive Care Syndrome in Pediatrics (PICS-p)- a Cross-sectional Survey
Journal of Pediatric Intensive Care · 2026
Efficacy and safety of golimumab biosimilar BAT2506 in patients with active psoriatic arthritis after switching from reference golimumab: 52-week results of a phase 3, double-blind, randomized study
Expert Opinion on Biological Therapy · 2026
Diagnostic Performance of Mobile Low‐Field MRI and CT for Acute Headache as the Isolated Clinical Manifestation in the Neurology Emergency Department
CNS Neuroscience & Therapeutics · 2026
Deucravacitinib in Active Psoriatic Arthritis: Efficacy and Safety up to 52 Weeks From the Randomized, Double‐Blind, Phase 3 POETYK PsA‐2 Trial
Arthritis & Rheumatology · 2026
Dermatomycosis incidence in the Russian Federation for 2020—2024
Russian Journal of Clinical Dermatology and Venereology · 2026
Association of the triglyceride-glucose index with the severity and short-term prognosis of Guillain-Barré syndrome
Frontiers in Immunology · 2026
Experience over tools: does the use of magnifying loupes reduce the incidence of transient postoperative hypocalcemia after total thyroidectomy with central neck dissection? – a single-centre prospective randomized study
Frontiers in Endocrinology · 2026
Intravenous Tenecteplase Prior to Endovascular Treatment for Ischemic Stroke at 4.5 to 24 Hours
JAMA · 2026
Comparing the efficacy and safety of biosimilar BAT2506 with reference golimumab in patients with active psoriatic arthritis: 24-week results of a phase 3, multicenter, double-blind, randomized, parallel-group study
Expert Opinion on Biological Therapy · 2026
Real-World Effectiveness and Safety of Tirzepatide, Semaglutide, and Liraglutide in Adults with Overweight or Obesity without Diabetes: A Comparative Study
Diabetes Metabolic Syndrome and Obesity · 2026
Comparative effectiveness of semaglutide and dulaglutide combined with hypocaloric diet in newly diagnosed type 2 diabetes: a retrospective real-world study
BMC Endocrine Disorders · 2026
Diagnostic biomarkers for differentiating AQP4-IgG- negative NMOSD from other nervous system autoimmune disorders: a retrospective study
Frontiers in Immunology · 2026
Plasma plasmalogen levels and risk of lymph node positive breast cancer
2025
Algorithm of olfaction assessment in otorhinolaryngologist’s practice
Russian Rhinology · 2025
The role of Inflasinusans in the treatment of acute rhinosinusitis
Russian Bulletin of Otorhinolaryngology · 2025
Open-label, Multicenter, Randomized, Parallel-Group Comparative Study on the Utility of Telephone Follow-Up in Community Pharmacies for Detecting Triple Whammy in Patients with Multiple Drug Combinations
Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences) · 2025
Highly selective tyrosine kinase 2 inhibition with zasocitinib (TAK-279) improves outcomes in patients with active psoriatic arthritis: a randomised phase 2b study
Annals of the Rheumatic Diseases · 2025
Keratoconus in hereditary spastic paraplegia 15 and Kjellin syndrome: a case report
Ophthalmic Genetics · 2025
Efficacy and safety of izokibep in patients with active psoriatic arthritis: a randomised, double-blind, placebo-controlled, phase 2 study
Annals of the Rheumatic Diseases · 2025